What is N2OFF, Inc. stock?

N2OFF, Inc. Business Introduction

N2OFF, Inc. (NASDAQ: NITO), formerly known as Save Foods, Inc., is an innovative pioneer in the green technology and agricultural sectors. The company has strategically expanded its scope from food waste reduction to the massive environmental challenge of Nitrous Oxide (N2O) mitigation. As of 2024, N2OFF operates at the intersection of Agri-Food tech and CleanTech, aiming to reduce greenhouse gas emissions while enhancing global food security.

1. Core Business Segments

N2O Mitigation (CleanTech): Through its majority-owned subsidiary, NT00, N2OFF is developing breakthrough technology designed to significantly reduce Nitrous Oxide emissions in the agricultural sector. N2O is a greenhouse gas 300 times more potent than CO2 and is a primary driver of ozone depletion. The company targets the "Nitrogen Paradox"—the inefficiency of nitrogen-based fertilizers.
Save Foods (Agri-Food Tech): This legacy business focuses on post-harvest treatments. The company provides eco-friendly, "green" sanitizers that replace traditional toxic chemicals. These solutions extend the shelf life of fresh produce (such as citrus, berries, and avocados) and reduce the prevalence of food-borne pathogens like Salmonella and Listeria.
Solar Energy (New Frontier): In early 2024, N2OFF announced a strategic move into the renewable energy sector, specifically targeting solar PV projects through joint ventures in Europe (notably Germany and Italy).

2. Business Model Characteristics

Sustainability-Driven: N2OFF’s revenue model is increasingly tied to ESG (Environmental, Social, and Governance) mandates. By helping farmers and distributors reduce waste and emissions, the company taps into global carbon credit markets and regulatory compliance budgets.
Asset-Light & Scalable: The company focuses on R&D and strategic partnerships for distribution, allowing for rapid deployment of its liquid-based agricultural treatments without the heavy overhead of large-scale manufacturing facilities.

3. Core Competitive Moat

Proprietary Formulations: N2OFF holds a portfolio of patents and trade secrets related to its eco-friendly sanitizers and N2O reduction agents.
Regulatory Barriers: The company has successfully navigated rigorous food safety and environmental regulations in multiple jurisdictions (including the US and EU), creating a barrier for new entrants.
Strategic Partnerships: Collaborations with major agricultural distributors and research institutions provide a "pre-built" pipeline for product adoption.

4. Latest Strategic Layout

In mid-2024, the company underwent a formal rebranding to N2OFF, Inc. to reflect its pivot toward high-impact environmental technology. The latest strategy emphasizes diversification: moving beyond the laboratory to real-world infrastructure (Solar) and atmospheric protection (N2O reduction), aiming to create a multi-layered revenue stream from the global "Green Transition."

N2OFF, Inc. Development History

The history of N2OFF is defined by its evolution from a niche food safety laboratory to a diversified environmental technology holding company.

1. The Formative Years (2010s - 2020)

The company originated as Save Foods, focusing on the critical issue of food waste. During this period, the company invested heavily in R&D to develop natural alternatives to the harsh pesticides used on fruits and vegetables. The goal was to solve the problem of "from farm to fork" spoilage, which claims nearly 40% of all produce.

2. Public Listing and Market Validation (2021 - 2022)

In 2021, the company successfully listed on the Nasdaq Capital Market. This phase was marked by international expansion, securing pilots with major distributors in Mexico, the United States, and Israel. The company proved that its "Green" treatments could effectively extend shelf life by several days, significantly improving the ROI for grocery retailers.

3. Strategic Pivot and Rebranding (2023 - 2024)

Recognizing the limitations of being a "single-product" company, the leadership initiated a transformation. In 2023, the company invested in NT00 to tackle Nitrous Oxide emissions. In early 2024, the company officially changed its name to N2OFF, Inc. and its ticker to NITO. This period also saw the expansion into renewable energy, signaling a commitment to becoming a broad-based CleanTech player.

4. Analysis of Success and Challenges

Success Drivers: Agility and vision. The management team identified that "Sustainability" was shifting from a buzzword to a regulatory requirement, allowing them to pivot into the N2O space before it became crowded.
Challenges: Like many micro-cap tech companies, N2OFF has faced volatility in its stock price and the need for frequent capital raises to fund R&D. Scaling "green" technology in the conservative agricultural industry requires long trial periods and high customer acquisition costs.

Industry Introduction

N2OFF operates within the Global CleanTech and AgTech industries, sectors that are currently experiencing massive capital inflows due to climate change urgency.

1. Industry Trends and Catalysts

Carbon Credit Evolution: The global voluntary carbon market is projected to reach billions of dollars by 2030. N2O mitigation is particularly valuable because its global warming potential is significantly higher than CO2.
Regulatory Pressure: The EU's "Farm to Fork" strategy and the Green Deal mandate a 50% reduction in chemical pesticide use by 2030, creating a vacuum that N2OFF’s products are designed to fill.

2. Market Data and Projections

3. Competitive Landscape

The competitive landscape is fragmented. In the food safety space, N2OFF competes with legacy chemical giants like AgroFresh (AGFS) and Decco. However, in the specific niche of N2O mitigation, N2OFF is one of the few publicly traded companies offering a direct play for investors.

4. Industry Positioning

N2OFF, Inc. characterizes itself as a High-Growth Disruptor. While it lacks the massive balance sheet of global chemical conglomerates, its specialization in "Nitrogen efficiency" and "Non-toxic sanitization" gives it a first-mover advantage in the burgeoning "Nature-Positive" economy. The company's recent entry into European solar projects further diversifies its risk, positioning it as a comprehensive ESG investment vehicle.

N2OFF, Inc. Financial Health Score

According to the latest financial statements, N2OFF, Inc. is currently at a critical stage of strategic transformation. Although the company achieved a modest single-quarter profit in Q3 2025, the cumulative annual loss remains substantial, with a financial structure characterized by high risk and high volatility.

Overall Score: 56 / 100
Note: Scores are based on data disclosed by Macrotrends and the latest NASDAQ financial reports.

N2OFF, Inc. Growth Potential

1. Strategic Transformation: From Clean Technology to Computational Biology

In February 2026, the company officially renamed itself Nexentis Technologies (NASDAQ: NXTS), marking a complete shift in business focus from traditional agricultural technology and solar energy to AI-driven computational biology. This transformation aims to leverage the core technology of MitoCareX Bio Ltd., acquired in October 2025, to develop novel therapies targeting hard-to-treat cancers such as pancreatic cancer and non-small cell lung cancer.

2. Cash Flow Support from Solar and Energy Storage Businesses

Despite the shift in focus, N2OFF continues to hold key solar assets in Europe through its subsidiary NITO Renewable Energy, Inc.
· Germany Project: Developing a 111 MWp photovoltaic project in Melz, with grid connection permits secured.
· Italy Project: Developing two battery energy storage systems (BESS) with a total capacity of 196 MWp in Sicily.
These assets, upon reaching the "Ready-to-Build" stage, are expected to generate significant cash inflows through sale or joint ventures, supporting the high expenditures of biopharmaceutical R&D.

3. Core Technology Catalyst: MITOLINE™ Discovery Engine

The company’s current core asset is the MITOLINE™ discovery engine, a platform specialized in drug screening targeting mitochondrial carrier proteins (SLC25 family). This unique biochemical pathway is highly scarce in tumor metabolism research and may become a key bargaining chip for future licensing agreements or acquisitions with major pharmaceutical companies (Big Pharma).

N2OFF, Inc. Company Pros and Cons

Pros

· Increased Cash Reserves: As of the end of September 2025, cash reserves increased to $6 million through financing activities, expected to support operations until Q3 2026.
· Entry into High-Growth Sectors: Moving into AI healthcare and oncology drug development enhances market expectations for valuation premiums.
· Asset Diversification: Possesses a triple asset profile in agricultural technology, photovoltaic projects, and biopharmaceuticals, providing some risk hedging capability.

Cons

· Going Concern Risk: Management explicitly highlighted significant doubts about the company’s ability to continue as a going concern in SEC filings, heavily reliant on subsequent financing.
· Delisting Pressure: Although recent reverse stock splits temporarily maintained share price, failure to meet transformation milestones may again expose the stock to NASDAQ compliance risks.
· High R&D Risk: Computational biology and new drug development involve long cycles, high costs, and very low success rates; all medical projects are currently in early pre-clinical stages with no revenue generated.
· Business Integration Challenges: Frequent name changes and strategic shifts may lead to dispersed management resources.

كيف ينظر المحللون إلى أسهم N2OFF, Inc. و NITO؟

حتى أوائل عام 2024 ومع اقتراب منتصف العام، يعكس شعور المحللين تجاه شركة N2OFF, Inc. (المعروفة سابقًا باسم Save Foods, Inc.) حالة انتقال استراتيجي كبيرة. بعد إعادة العلامة التجارية وتوسعها من التكنولوجيا الزراعية إلى قطاع الطاقة المتجددة، تغيرت وجهة نظر وول ستريت من تقييم لاعب متخصص في تكنولوجيا الأغذية إلى تحليل شركة قابضة متنوعة. وبينما لا تزال الأسهم كيانًا صغيرًا ذات تقلبات متأصلة، يراقب المحللون عن كثب استراتيجية النمو "ذات المسارين".

1. وجهات النظر المؤسسية الأساسية حول الشركة

التحول الاستراتيجي نحو الطاقة المتجددة: يبرز معظم المراقبين في السوق استحواذ الشركة مؤخرًا على حصة 15% في مشروع شمسي ألماني كبير من خلال شركتها الفرعية NT Solar. يُنظر إلى هذه الخطوة في مجال "التكنولوجيا النظيفة" على أنها تحول تكتيكي لاقتناص الطلب المتزايد على البنية التحتية المتجددة في أوروبا. يعتقد المحللون أن هذا التنويع قد يوفر قاعدة إيرادات أكثر استقرارًا مقارنة بسوق التكنولوجيا الزراعية عالية التقلب.
الاستمرار في مجال التكنولوجيا الزراعية: على الرغم من التحول نحو الطاقة، تحافظ N2OFF على نشاطها الأساسي Save Foods الذي يركز على تقليل هدر الطعام والحد من استخدام المبيدات. يشير محللو شركات متخصصة إلى أن حلول "الزراعة الخضراء" للشركة لا تزال ذات صلة مع تشديد متطلبات ESG (البيئية والاجتماعية والحوكمة) عالميًا، رغم أن التبني التجاري كان أبطأ مما كان متوقعًا.
هيكل رأس المال والسيولة: موضوع متكرر في ملاحظات المحللين هو تركيز الشركة على الحفاظ على الامتثال لقواعد NASDAQ. بعد تنفيذ عملية دمج عكسي للأسهم بنسبة 1 إلى 10 في أوائل 2024، يركز الباحثون المؤسسيون على ما إذا كانت الشركة قادرة على استخدام ميزانيتها المعاد هيكلتها لتمويل المزيد من الاستحواذات في قطاع الطاقة الشمسية.

2. تقييمات الأسهم واتجاهات التقييم

نظرًا لوضعها كشركة صغيرة (تتقلب قيمتها السوقية عادةً دون 10 ملايين دولار)، لا تحظى N2OFF بنفس نطاق التغطية التي تحظى بها الأسهم الكبيرة، لكن البيانات المتاحة تشير إلى إجماع "شراء مضاربي" أو "احتفاظ" بين المحللين المتخصصين:
حركة السعر والأهداف: شهد السهم تقلبات شديدة في الربع الأول من 2024 عقب إعلان استثماراته في الطاقة الشمسية. وضع بعض مزودي الأبحاث المستقلين تقديرات "القيمة العادلة" المضاربية أعلى بكثير من سعر التداول الحالي (غالبًا في نطاق 1.50 إلى 3.00 دولار بعد التقسيم)، معتمدين على نجاح دمج إيرادات الطاقة.
الملكية المؤسسية: تظهر ملفات SEC الأخيرة أن الملكية المؤسسية لا تزال منخفضة، لكن الشركة نجحت في جذب استثمارات خاصة لتمويل توسعها. يرى المحللون أن هذه الزيادات في رأس المال تعكس ثقة في اتجاه الإدارة الجديد، مع تحذير من احتمال تخفيف حصص المستثمرين الأفراد الحاليين.

3. عوامل المخاطر التي حددها المحللون (السيناريو السلبي)

يحذر المحللون المستثمرين من عدة مخاطر ذات تأثير كبير مرتبطة بـ NITO:
مخاطر التنفيذ في الأسواق الجديدة: الانتقال من تكنولوجيا الأغذية إلى الطاقة الشمسية يتطلب خبرات تشغيلية مختلفة تمامًا. يعبر المحللون عن قلقهم بشأن قدرة فريق الإدارة الصغير على الإشراف الفعال على صناعتين مختلفتين في الوقت نفسه.
الاعتماد على التنظيم والدعم المالي: تتأثر المشاريع الشمسية في ألمانيا بشكل كبير بسياسات الاتحاد الأوروبي للطاقة والدعم المالي. قد تؤثر التغيرات في المشهد الجيوسياسي أو تقليص الحوافز للطاقة المتجددة سلبًا على العوائد المتوقعة من الاستثمارات الأخيرة.
تقلبات الشركات الصغيرة: مع انخفاض حجم التداول اليومي، تتعرض NITO لتقلبات سعرية كبيرة بناءً على أخبار بسيطة. يصنف المحللون الماليون السهم غالبًا على أنه "عالي المخاطر"، مناسب فقط للمستثمرين الذين يتحملون تقلبات رأس المال العالية.

الملخص

الإجماع حول N2OFF, Inc. هو حالة "تحول مراقب عن كثب". لم تعد الشركة مجرد مزود لحلول هدر الطعام؛ بل أصبحت لاعبًا ناشئًا في مجال البنية التحتية للطاقة الشمسية الأوروبية. بينما تشير إعادة العلامة التجارية في 2024 إلى بداية جديدة، يتفق المحللون على أن أداء السهم في النصف الثاني من العام سيعتمد كليًا على "إثبات الإيرادات" من مصالحها الشمسية الألمانية وقدرتها على توسيع علاجاتها الزراعية الصديقة للبيئة دون تخفيف إضافي لحصص المساهمين.

N2OFF, Inc. (NITO) Frequently Asked Questions

What are the primary investment highlights for N2OFF, Inc. (NITO), and who are its main competitors?

N2OFF, Inc. (formerly known as Save Foods, Inc.) is an agri-food technology company focused on two main pillars: reducing food waste and mitigating greenhouse gas emissions, specifically nitrous oxide (N2O). A key investment highlight is its subsidiary, NTWO OFF Ltd., which aims to deliver innovative solutions for the agriculture sector to reduce synthetic fertilizer usage, thereby lowering carbon footprints.
In the food preservation sector, its Save Foods Ltd. subsidiary provides eco-friendly solutions to extend the shelf life of fresh produce. Its main competitors include established agrochemical giants such as Corteva (CTVA) and FMC Corporation (FMC), as well as specialized food-tech companies like Apeel Sciences and AgroFresh Solutions.

Is the latest financial data for N2OFF, Inc. healthy? What are the current revenue and net loss figures?

According to the most recent Form 10-Q filings for 2024, N2OFF, Inc. remains an early-stage growth company facing financial challenges typical of the micro-cap tech sector. For the quarter ended June 30, 2024, the company reported limited revenue as it continues to transition its business model.
The company has historically operated at a net loss due to high research and development (R&D) and administrative expenses. As of mid-2024, the company maintained a cash position supported by recent financing efforts but continues to face a "going concern" risk if it cannot achieve profitability or secure additional funding. Investors should note that the accumulated deficit remains a significant item on the balance sheet.

Is the current NITO stock valuation high? How do the P/E and P/S ratios compare to the industry?

As of late 2024, NITO has a negative Price-to-Earnings (P/E) ratio because the company is not yet profitable. This is common among developmental-stage agri-tech firms. Its Price-to-Sales (P/S) ratio tends to be highly volatile due to fluctuating quarterly revenues.
Compared to the broader Agricultural Chemicals industry, NITO is considered a high-risk, high-reward micro-cap stock. Its valuation is driven more by its intellectual property (IP) and the potential market size for nitrous oxide reduction rather than current earnings multiples.

How has NITO stock performed over the past three months and the past year?

NITO stock has experienced significant volatility over the past year. In 2024, the stock underwent a 1-for-10 reverse stock split to meet Nasdaq's minimum bid price requirements. Over the past three months, the stock has seen sharp fluctuations driven by corporate rebranding and announcements regarding its clean-tech initiatives.
Compared to the S&P 500 and the Invesco DB Agriculture Fund (DBA), NITO has generally underperformed broader market benchmarks over a one-year period, reflecting the inherent risks of small-cap biotech and agri-tech investments.

Are there any recent industry tailwinds or headwinds affecting N2OFF, Inc.?

The primary tailwind for N2OFF is the global push toward ESG (Environmental, Social, and Governance) standards and the "Net Zero" transition. Government incentives for carbon credit generation and regulations targeting nitrous oxide emissions provide a favorable regulatory environment.
Conversely, the headwinds include high interest rates, which increase the cost of capital for pre-revenue companies, and the slow adoption rate of new technologies in the traditional agricultural sector. Any shift in global climate policy could significantly impact demand for N2O reduction technologies.

Have any major institutional investors bought or sold NITO stock recently?

Institutional ownership in N2OFF, Inc. remains relatively low, which is typical for a company of its market capitalization. According to Fintel and SEC 13F filings, the majority of shares are held by retail investors and company insiders.
While there has been some participation from smaller micro-cap funds, there has not been significant "whale" activity from major institutions like BlackRock or Vanguard in recent quarters. Investors should monitor Form 4 filings for insider buying, which can serve as a signal of management's confidence in the new strategic direction toward emission reduction.